HYQVIA is indicated for the treatment of primary immunodeficiency (PI) in adults. HYQVIA is for subcutaneous use only. Safety and efficacy of chronic use of Recombinant Human Hyaluronidase in HYQVIA have not been established in conditions other than PI.


Contact your representative.

Get answers to your questions. Talk to a representative about HYQVIA.

Your local Takeda representative is ready to support you and help answer your questions about HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase]. Simply enter your ZIP code below to get in touch with your dedicated TAKEDA representative, or call 1-877-825-3327 to speak with customer service.

*Indicates a required field.

We respect your privacy. By submitting this form, I understand that the information I have provided will be used by Takeda and its contracted third parties to contact me by mail, email, and phone with helpful information on Takeda treatments and indicated conditions. Takeda will not sell or transfer my name or contact information to any third party for their marketing use.

If you ever decide that you do not wish to receive this information from us, contact us at Consumer Relations, Takeda Pharmaceutical Company Limited, 300 Shire Way, Lexington, MA 02421 or at 1-877-825-3327. For general questions, please refer to our Global Privacy Policy.